Vimarsana
Biggest News Aggregation in the World

Page 2 - Randomised Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomised Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomised Evaluation Today - Breaking & Trending Today

The Galien Foundation Presents 2023 Prix Galien UK Awards at the Natural History Museum, London - Vimarsana News

The Galien Foundation Presents 2023 Prix Galien UK Awards at the Natural History Museum, London

-- Winners represent excellence in scientific innovation in pharmaceuticals, biotechnology, medical technology, digital health, and the public sector LONDON, May 12, 2023 /PRNewswire/ --

The Galien Foundation Announces 2023 Prix Galien UK Award Candidates for Best Biotechnology Product, Best Digital Health Solution, Best Medical Technology, Best Pharmaceutical Product and Newly Added, Best Public Sector Innovation - Vimarsana News

The Galien Foundation Announces 2023 Prix Galien UK Award Candidates for Best Biotechnology Product, Best Digital Health Solution, Best Medical Technology, Best Pharmaceutical Product and Newly Added, Best Public Sector Innovation

-- Winners to be Announced and Recognised on 11 May at the Prix Galien UK Awards Ceremony in London LONDON, May 2, 2023 /PRNewswire/ -- The Galien Foundation, the premier global institution

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial - Vimarsana News

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

In patients hospitalised for COVID-19 with clinical hypoxia who required either no oxygen or simple oxygen only, higher dose corticosteroids significantly increased the risk of death compared with usual care, which included low-dose corticosteroids. The RECOVERY trial continues to assess the effects of higher dose corticosteroids in patients hospitalised with COVID-19 who require non-invasive ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation.

The big idea: should governments run more experiments? - Vimarsana News

The big idea: should governments run more experiments?

We’re used to randomised trials in medicine. Why not apply the same rigour to policy?

The approach to informed consent in acute care research – Authors' reply - Vimarsana News

The approach to informed consent in acute care research – Authors' reply

Rafael Dal-Ré and Arthur L Caplan state that obtaining consent “was clearly not an issue in RECOVERY [the Randomised Evaluation of COVID-19 Therapy trial]” and use this statement to support their supposition that there is “no need” to reconsider regulations for written informed consent obtained prospectively from acutely ill patients. However, in the RECOVERY trial,1 if no family member was available, patients who lacked capacity to consent could be enrolled without providing informed consent through the involvement of a doctor (independent of the study team) who could act as the lega...